Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA‐1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation

Prior to transplantation of hematopoietic stem cells or solid organ, donor and recipient EBV serostatus has to be determined to assess risks of post‐transplant lymphoproliferative disorders. Sensitivity of EBV Viral capsid antigens (VCA) IgG and EBV nuclear antigen‐1 (EBNA‐1) is critical to define p...

Ausführliche Beschreibung